First human trial launches for experimental cancer drug targeting tough tumors
NCT ID NCT06997029
Summary
This is a first-in-human study to test the safety and dosing of an experimental drug called BMS-986500. It will be given alone to people with various advanced solid tumors and in combination with other drugs to people with advanced breast cancer that has stopped responding to prior therapy. The main goal is to find a safe dose and understand how the body processes the drug.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Dana-Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
Contact Phone: •••-•••-••••
-
Dartmouth-Hitchcock Medical Center
RECRUITINGLebanon, New Hampshire, 03756, United States
Contact Phone: •••-•••-••••
-
Hoag Memorial Hospital Presbyterian
RECRUITINGNewport Beach, California, 92663, United States
Contact Phone: •••-•••-••••
-
Kansai Medical University Hospital
RECRUITINGHirakata, Osaka, 573-1191, Japan
Contact Phone: •••-•••-••••
-
Local Institution - 0008
NOT_YET_RECRUITINGAurora, Colorado, 80045, United States
Contact
-
Local Institution - 0011
NOT_YET_RECRUITINGNew York, New York, 10016, United States
Contact
-
Local Institution - 0014
NOT_YET_RECRUITINGBuffalo, New York, 14263, United States
Contact
-
Local Institution - 0021
NOT_YET_RECRUITINGKashiwa, Chiba, 277-8577, Japan
Contact
-
Local Institution - 0024
NOT_YET_RECRUITINGOdense, Region Syddanmark, 5000, Denmark
Contact
-
Local Institution - 0025
NOT_YET_RECRUITINGCopenhagen, 2100, Denmark
Contact
-
Marin Cancer Care
RECRUITINGGreenbrae, California, 94904, United States
Contact Phone: •••-•••-••••
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 10065, United States
Contact Phone: •••-•••-••••
-
Moores Cancer Center
RECRUITINGLa Jolla, California, 92093, United States
Contact Phone: •••-•••-••••
-
NEXT Oncology
RECRUITINGSan Antonio, Texas, 78229, United States
Contact Phone: •••-•••-••••
-
National Cancer Center Hospital
RECRUITINGChuo-ku, Tokyo, 104-0045, Japan
Contact Phone: •••-•••-••••
-
Northwell Health-Cancer Institute
RECRUITINGNew Hyde Park, New York, 11042, United States
Contact
-
Providence St. Jude Medical Center
RECRUITINGFullerton, California, 92835, United States
Contact Phone: •••-•••-••••
-
START Dallas Fort Worth
RECRUITINGFort Worth, Texas, 76104, United States
Contact Phone: •••-•••-••••
-
The Cancer Institute Hospital of JFCR
RECRUITINGKoto-ku, Tokyo, 135-8550, Japan
Contact Phone: •••-•••-••••
-
University of Alabama at Birmingham
RECRUITINGBirmingham, Alabama, 35294-3300, United States
Contact Phone: •••-•••-••••
-
Washington University School of Medicine
RECRUITINGSt Louis, Missouri, 63110, United States
Contact
Conditions
Explore the condition pages connected to this study.